An augmentation to standard treatment of pancreatic ductal adenocarcinoma using five repurposed drugs
In a new paper, researcher Richard E. Kast from IIAIGC Study Center presents the data and rationale for adding five generic non-oncology drugs from general medical practice to gemcitabine, nab-paclitaxel, a current standard ...
Feb 12, 2024
0
49
